TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 21282528

Group type: EXPERIMENTAL
Intervention: Mobilisation and Tactile Stimulation (MTS) for 30, 60, or 120 minutes daily for 14 days
Number of subjects: 76

Group type: COMPARATOR
Intervention: Conventional rehabilitation (control group) with no extra therapy
Number of subjects: 76
Study: 19411747

Group type: EXPERIMENTAL
Intervention: Antidepressant and psychological intervention
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine treatment alone (Control)
Number of subjects: 60
Study: 17575244

Group type: EXPERIMENTAL
Intervention: Powerful individuals
Number of subjects: 0

Group type: COMPARATOR
Intervention: Powerless individuals
Number of subjects: 0
Study: 15762362

Group type: EXPERIMENTAL
Intervention: Intraoperative evaluation of surgical margins (IESM)
Number of subjects: 251

Group type: COMPARATOR
Intervention: Classical quadrantectomy without IESM (Control)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Overall survival (IESM)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Local recurrence-free survival (IESM)
Number of subjects: 251

Group type: EXPERIMENTAL
Intervention: Distant metastasis-free survival (IESM)
Number of subjects: 251
Study: 11867396

Group type: EXPERIMENTAL
Intervention: Epidural fentanyl with bupivacaine 0.015% and epinephrine
Number of subjects: 100

Group type: COMPARATOR
Intervention: IV fentanyl
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine 0.015% with epinephrine
Number of subjects: 100
Study: 9741604

Group type: EXPERIMENTAL
Intervention: Aircast Sport-Stirrup
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Active Ankle
Number of subjects: 24

Group type: COMPARATOR
Intervention: No brace (control)
Number of subjects: 24
Study: 7857354

Group type: EXPERIMENTAL
Intervention: Pidotimod (400 mg oral bottle daily)
Number of subjects: 416

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 416
Study: 2806595

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate initiated on the 2nd day of the menstrual cycle
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate initiated on the 3rd day of the menstrual cycle
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate initiated on the 4th day of the menstrual cycle
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate initiated on the 5th day of the menstrual cycle
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Clomiphene citrate overall
Number of subjects: 87

Group type: EXPERIMENTAL
Intervention: Cycles with luteal dysfunction
Number of subjects: 87
Study: 1054855

Group type: EXPERIMENTAL
Intervention: 0.5% chlorhexidine gluconate gel
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 12
Study: 31529767

Group type: EXPERIMENTAL
Intervention: Prophylactic azithromycin
Number of subjects: 26

Group type: COMPARATOR
Intervention: No azithromycin
Number of subjects: 26
Study: 30808282

Group type: EXPERIMENTAL
Intervention: DTP1 vaccination in Dar es Salaam
Number of subjects: 30156

Group type: EXPERIMENTAL
Intervention: DTP3 vaccination in Dar es Salaam
Number of subjects: 30156

Group type: EXPERIMENTAL
Intervention: DTP1 vaccination in Morogoro
Number of subjects: 30156

Group type: EXPERIMENTAL
Intervention: DTP3 vaccination in Morogoro
Number of subjects: 30156

Group type: EXPERIMENTAL
Intervention: Maternal education in Morogoro
Number of subjects: 30156

Group type: EXPERIMENTAL
Intervention: Paternal education in Morogoro
Number of subjects: 30156

Group type: EXPERIMENTAL
Intervention: Antenatal care visit timing in Dar es Salaam
Number of subjects: 30156

Group type: EXPERIMENTAL
Intervention: Home birth in Morogoro
Number of subjects: 30156

Group type: EXPERIMENTAL
Intervention: Younger maternal age and poorer households
Number of subjects: 30156
Study: 28506305

Group type: EXPERIMENTAL
Intervention: Chemotherapy counseling module by pharmacists
Number of subjects: 162
Study: 25594768

Group type: EXPERIMENTAL
Intervention: n-CAP dentifrice
Number of subjects: 82

Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser
Number of subjects: 82

Group type: COMPARATOR
Intervention: strontium chloride dentifrice (SC)
Number of subjects: 82
Study: 24006673

Group type: EXPERIMENTAL
Intervention: Acupuncture stimulation of Neiguan (PC 6)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control (no treatment)
Number of subjects: 60
Study: 21214685

Group type: EXPERIMENTAL
Intervention: Psychosocial intervention (PSI) training
Number of subjects: 42

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 42
Study: 18082830

Group type: EXPERIMENTAL
Intervention: Sodium dodecyl sulfate polyacrylamide gel electrophoresis with silver staining
Number of subjects: 18

Group type: COMPARATOR
Intervention: Healthy controls
Number of subjects: 18
Study: 17467889

Group type: COMPARATOR
Intervention: BoNTA 300U
Number of subjects: 59

Group type: COMPARATOR
Intervention: BoNTA 200U
Number of subjects: 59

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 59
Study: 14754789

Group type: EXPERIMENTAL
Intervention: Clozapine
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Risperidone
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 11587599

Group type: COMPARATOR
Intervention: Assistive listening device
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional hearing aid (nonprogrammable)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Programmable hearing aid (directional microphone)
Number of subjects: 60

Group type: COMPARATOR
Intervention: No amplification (control)
Number of subjects: 60
Study: 9120506

Group type: EXPERIMENTAL
Intervention: Community health RCTs
Number of subjects: 603

Group type: COMPARATOR
Intervention: Non-randomized studies
Number of subjects: 603

Group type: EXPERIMENTAL
Intervention: Overall RCTs
Number of subjects: 603
Study: 8506888

Group type: EXPERIMENTAL
Intervention: Computerized ambulatory medical record system with health care maintenance reminders
Number of subjects: 49

Group type: COMPARATOR
Intervention: Conventional paper record with health care maintenance flow sheet
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Computerized ambulatory medical record system
Number of subjects: 49
Study: 2979690

Group type: EXPERIMENTAL
Intervention: Omeprazole (40 mg intravenous)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 28945118

Group type: EXPERIMENTAL
Intervention: NAVIGATE
Number of subjects: 404

Group type: COMPARATOR
Intervention: Community Care
Number of subjects: 404
Study: 27231000

Group type: EXPERIMENTAL
Intervention: 20 min e-learning intervention focused on the fundamentals of the flags approach to clinical judgement-making regarding risk of future pain-related disability
Number of subjects: 0

Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 0
Study: 25329159

Group type: EXPERIMENTAL
Intervention: n‐3 long‐chain polyunsaturated fatty acids (n‐3 LCPUFA) 4 g daily for 8 weeks
Number of subjects: 0

Group type: COMPARATOR
Intervention: Olive oil (OO) 4 g daily for 8 weeks
Number of subjects: 0
Study: 23768666

Group type: EXPERIMENTAL
Intervention: Rumination task
Number of subjects: 37

Group type: COMPARATOR
Intervention: Distraction control condition
Number of subjects: 37
Study: 20042560

Group type: EXPERIMENTAL
Intervention: Duration of diabetes of 20 or more years
Number of subjects: 2368

Group type: EXPERIMENTAL
Intervention: Microalbuminuria
Number of subjects: 2368

Group type: EXPERIMENTAL
Intervention: Macroalbuminuria
Number of subjects: 2368

Group type: EXPERIMENTAL
Intervention: Duration of diabetes
Number of subjects: 2368
Study: 17467944

Group type: EXPERIMENTAL
Intervention: Contrast Enhanced Intraoperative Ultrasound (CE-IOUS)
Number of subjects: 39

Group type: COMPARATOR
Intervention: Combination of preoperative CE-CT and IOUS
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: CE-IOUS
Number of subjects: 39
Study: 16955301

Group type: EXPERIMENTAL
Intervention: LigaSure
Number of subjects: 100

Group type: COMPARATOR
Intervention: Conventional suture ligation technique
Number of subjects: 100
Study: 12709699

Group type: EXPERIMENTAL
Intervention: Prophylactic clip placement
Number of subjects: 413

Group type: COMPARATOR
Intervention: No clip (control)
Number of subjects: 413
Study: 11256057

Group type: COMPARATOR
Intervention: Five structured clinical interviews (SCI-PAS, SCI-MOODS, SCI-SHY, SCI-OBS, SCI-ABS) administered along with a diagnostic interview and self-report instruments.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Panic-agoraphobia spectrum assessment with defined cut-off score.
Number of subjects: 0

Group type: COMPARATOR
Intervention: Self-report instruments assessing eating disorders.
Number of subjects: 0
Study: 9346220

Group type: EXPERIMENTAL
Intervention: Paclitaxel (175 mg/m2 over 3 hours) with carboplatin (AUC 5)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Paclitaxel (175 mg/m2 over 3 hours) with cisplatin (75 mg/m2)
Number of subjects: 145
Study: 8452174

Group type: EXPERIMENTAL
Intervention: Fleroxacin 400 mg orally once daily for 4-21 days
Number of subjects: 285

Group type: COMPARATOR
Intervention: Amoxicillin/clavulanate potassium (AMX/CP) 500 mg/125 mg orally three times daily for 4-21 days
Number of subjects: 285
Study: 3544698

Group type: EXPERIMENTAL
Intervention: Tobacco abstinence condition
Number of subjects: 70
Study: 30713173

Group type: EXPERIMENTAL
Intervention: Clear twin-block
Number of subjects: 62

Group type: COMPARATOR
Intervention: Classic twin-block
Number of subjects: 62
Study: 27707723

Group type: EXPERIMENTAL
Intervention: Hot water immersion at 40.5°C for 60 minutes
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control (seated rest for 60 minutes)
Number of subjects: 10
Study: 24767423

Group type: EXPERIMENTAL
Intervention: adapted-NFPP
Number of subjects: 329

Group type: EXPERIMENTAL
Intervention: IY
Number of subjects: 329

Group type: COMPARATOR
Intervention: TAU
Number of subjects: 329
Study: 22480794

Group type: EXPERIMENTAL
Intervention: Tinzaparin (175 IU/kg)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Dalteparin (200 IU/kg)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Tinzaparin
Number of subjects: 29

Group type: COMPARATOR
Intervention: Dalteparin
Number of subjects: 29
Study: 20418272

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 7599

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7599
Study: 18361438

Group type: EXPERIMENTAL
Intervention: D-amphetamine (0.5 mg/kg)
Number of subjects: 0

Group type: COMPARATOR
Intervention: AMPT (3 g/70 kg/day over 44 h)
Number of subjects: 0
Study: 16181877

Group type: EXPERIMENTAL
Intervention: Leukocyte filter
Number of subjects: 159

Group type: COMPARATOR
Intervention: Conventional filter
Number of subjects: 159
Study: 11921113

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 199
Study: 9810937

Group type: EXPERIMENTAL
Intervention: Dizzy subjects
Number of subjects: 262

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 262
Study: 8589783

Group type: EXPERIMENTAL
Intervention: Ketogenic diet
Number of subjects: 21

Group type: COMPARATOR
Intervention: Nonketogenic diet
Number of subjects: 21
Study: 3287703

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (16 mg/kg/day IV for 3 days, then 400 mg t.i.d. for 28 days)
Number of subjects: 297

Group type: EXPERIMENTAL
Intervention: Pentoxifylline
Number of subjects: 297

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 297
Study: 30063303

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Fluoxetine
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Light therapy
Number of subjects: 122

Group type: EXPERIMENTAL
Intervention: Combination group (Fluoxetine + Light therapy)
Number of subjects: 122
Study: 28844192

Group type: EXPERIMENTAL
Intervention: Rivaroxaban (2.5 mg twice daily) plus Aspirin (100 mg once daily)
Number of subjects: 27395

Group type: COMPARATOR
Intervention: Rivaroxaban (5 mg twice daily)
Number of subjects: 27395

Group type: COMPARATOR
Intervention: Aspirin (100 mg once daily)
Number of subjects: 27395
Study: 26250486

Group type: EXPERIMENTAL
Intervention: Selenium supplementation (200 μg as tablet for 6 weeks)
Number of subjects: 70
Study: 24558759

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate 5.0 mg/kg (group A)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Magnesium sulfate 7.5 mg/kg (group B)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Saline (group C)
Number of subjects: 60
Study: 21332932

Group type: EXPERIMENTAL
Intervention: Etoricoxib 30 mg/day
Number of subjects: 1207

Group type: EXPERIMENTAL
Intervention: Celecoxib 200 mg/day
Number of subjects: 1207

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1207
Study: 19568990

Group type: EXPERIMENTAL
Intervention: 0.1% dexamethasone (DEX group)
Number of subjects: 37

Group type: COMPARATOR
Intervention: 1% rimexolone (RIMEX group)
Number of subjects: 37
Study: 17100744

Group type: EXPERIMENTAL
Intervention: TiUnite implants
Number of subjects: 15

Group type: COMPARATOR
Intervention: Turned implants
Number of subjects: 15
Study: 15301100

Group type: EXPERIMENTAL
Intervention: Liquefacient nitrogen cryotherapy with antibiotic eye drops and ointments
Number of subjects: 126

Group type: COMPARATOR
Intervention: Antibiotic eye drops and 2% yellow mercury oxide ointments (Control)
Number of subjects: 126
Study: 11181670

Group type: EXPERIMENTAL
Intervention: Chemotherapy
Number of subjects: 6232
Study: 9329359

Group type: EXPERIMENTAL
Intervention: Octreotide (OCT) treatment (150-600 micrograms/day for 3-6 months)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Octreotide (OCT) treatment
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Octreotide (OCT) treatment with low carbohydrate intake
Number of subjects: 59

Group type: COMPARATOR
Intervention: Untreated group
Number of subjects: 59
Study: 8201559

Group type: COMPARATOR
Intervention: Monofocal intraocular lens
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Multifocal intraocular lens
Number of subjects: 80
Study: 3987179

Group type: EXPERIMENTAL
Intervention: Doxylamine alone (S)
Number of subjects: 2931

Group type: EXPERIMENTAL
Intervention: Acetaminophen alone (A)
Number of subjects: 2931

Group type: EXPERIMENTAL
Intervention: Combination of doxylamine and acetaminophen (C)
Number of subjects: 2931

Group type: COMPARATOR
Intervention: Placebo (P)
Number of subjects: 2931
Study: 30371904

Group type: EXPERIMENTAL
Intervention: Acetaminophen (1000 mg)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 27467003

Group type: EXPERIMENTAL
Intervention: Black hood assisted colonoscopy (BHAC)
Number of subjects: 1076

Group type: COMPARATOR
Intervention: Conventional colonoscopy (CC)
Number of subjects: 1076
Study: 24247476

Group type: EXPERIMENTAL
Intervention: Glucagon-like peptide-1 (1.5 pmol/kg/min) plus intensive insulin therapy
Number of subjects: 18

Group type: COMPARATOR
Intervention: Normal saline plus intensive insulin therapy
Number of subjects: 18
Study: 22607579

Group type: EXPERIMENTAL
Intervention: Netazepide 5 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Netazepide 25 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Netazepide 100 mg
Number of subjects: 32

Group type: COMPARATOR
Intervention: Netazepide (0.5-100 mg)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Ranitidine 150 mg
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Netazepide
Number of subjects: 32
Study: 20673995

Group type: EXPERIMENTAL
Intervention: Naltrexone 32 mg plus bupropion 360 mg per day
Number of subjects: 1742

Group type: EXPERIMENTAL
Intervention: Naltrexone 16 mg plus bupropion 360 mg per day
Number of subjects: 1742

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1742
Study: 18577032

Group type: EXPERIMENTAL
Intervention: Pimecrolimus cream 1%
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vehicle
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pimecrolimus cream 1% and Vehicle
Number of subjects: 0
Study: 17161977

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg/kg body weight)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9
Study: 15316475

Group type: EXPERIMENTAL
Intervention: Fuji Ortho LC (resin-modified glass ionomer adhesive)
Number of subjects: 398

Group type: COMPARATOR
Intervention: Light Bond (conventional resin adhesive)
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Fuji Ortho LC
Number of subjects: 398

Group type: COMPARATOR
Intervention: Light Bond
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Both adhesives
Number of subjects: 398
Study: 10847232

Group type: EXPERIMENTAL
Intervention: Nifedipine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Prazosin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nifedipine and Prazosin
Number of subjects: 0
Study: 9084949

Group type: EXPERIMENTAL
Intervention: Iontophoresis of lidocaine HCl 2% with epinephrine 1:100,000
Number of subjects: 51

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 51
Study: 1286487

Group type: EXPERIMENTAL
Intervention: Glyburide
Number of subjects: 34

Group type: COMPARATOR
Intervention: Glipizide
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Glyburide and Glipizide
Number of subjects: 34
Study: 3993436

Group type: EXPERIMENTAL
Intervention: Single dose CPAF tests including facial skin temperature measurements
Number of subjects: 133

Group type: EXPERIMENTAL
Intervention: Skin temperature measurement methods (delta T, %T, delta MTCI)
Number of subjects: 133
Study: 31177999

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with 2-3 serves per week of fresh, lean pork (MedPork)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Low-fat control diet (LF)
Number of subjects: 33
Study: 28814395

Group type: EXPERIMENTAL
Intervention: Whole grain-rich (WG) diet for 6 weeks
Number of subjects: 80

Group type: COMPARATOR
Intervention: Refined grain-based (RG) diet for 6 weeks
Number of subjects: 80
Study: 25896121

Group type: EXPERIMENTAL
Intervention: Collaborative care (CC) intervention of pharmacotherapy and/or cognitive behavioral therapy
Number of subjects: 274

Group type: COMPARATOR
Intervention: Usual care (UC)
Number of subjects: 274
Study: 23726126

Group type: EXPERIMENTAL
Intervention: Multiphasic injection protocol (protocol I) with 89 mL of Optiray 350
Number of subjects: 30

Group type: COMPARATOR
Intervention: Test bolus injection protocol (protocol II) with a 10 mL test bolus of Optiray 350 followed by 40 mL of contrast medium
Number of subjects: 30
Study: 21702325

Group type: EXPERIMENTAL
Intervention: 0.454% stannous fluoride dentifrice
Number of subjects: 111

Group type: COMPARATOR
Intervention: 0.76% sodium monofluorophosphate dentifrice (negative control)
Number of subjects: 111
Study: 19485286

Group type: EXPERIMENTAL
Intervention: Topical cyclosporin A 1%
Number of subjects: 76

Group type: COMPARATOR
Intervention: No topical cyclosporin A
Number of subjects: 76
Study: 17027425

Group type: EXPERIMENTAL
Intervention: Sensitivity(ER)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Specificity(ER)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Screening tool reapplications
Number of subjects: 0
Study: 12716952

Group type: EXPERIMENTAL
Intervention: Blind subjects
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sighted subjects
Number of subjects: 0
Study: 11040714

Group type: EXPERIMENTAL
Intervention: Body-mind training (guided relaxation technique combined with meditative stretching)
Number of subjects: 8
Study: 9297399

Group type: EXPERIMENTAL
Intervention: Peritoneal dialysis (DP)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Exchange transfusion (ET) and hemodialysis (HD)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Hemodialysis (HD)
Number of subjects: 6

Group type: EXPERIMENTAL
Intervention: Exchange transfusion (ET) and peritoneal dialysis (DP)
Number of subjects: 6
Study: 8451895

Group type: EXPERIMENTAL
Intervention: 2 g Cefoxitin
Number of subjects: 243

Group type: COMPARATOR
Intervention: 1.5 g Cefuroxim
Number of subjects: 243
Study: 3457904

Group type: EXPERIMENTAL
Intervention: Tilt test, cold pressor test, treadmill and isometric exercise by handgrip
Number of subjects: 10
Study: 31299658

Group type: EXPERIMENTAL
Intervention: Routine care and educational program (video show, pamphlet, in-person counseling)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 199
Study: 28511288

Group type: COMPARATOR
Intervention: PRO‐TR (tele-health followup by rheumatologist)
Number of subjects: 294

Group type: COMPARATOR
Intervention: PRO‐TN (tele-health followup by nurse)
Number of subjects: 294

Group type: EXPERIMENTAL
Intervention: Control (conventional outpatient followup by physicians)
Number of subjects: 294
Study: 26938954

Group type: EXPERIMENTAL
Intervention: Early-treated group (surgery and orthodontic traction using the Guide rod appliance)
Number of subjects: 28

Group type: COMPARATOR
Intervention: Later-treated group (surgery and orthodontic traction using the Guide rod appliance)
Number of subjects: 28
Study: 25980148

Group type: EXPERIMENTAL
Intervention: Functional endoscopic sinus surgery (FESS)
Number of subjects: 78
Study: 23086696

Group type: EXPERIMENTAL
Intervention: Ibuprofen (800 mg/day to 1800 mg/day)
Number of subjects: 0
Study: 20103314

Group type: EXPERIMENTAL
Intervention: Low-dose heparin (150 IU/kg)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: High-dose heparin (300 IU/kg)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Both heparin groups (low-dose and high-dose)
Number of subjects: 42
Study: 18926127

Group type: EXPERIMENTAL
Intervention: Learner-centered nutrition education
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control lesson about resource management
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Learner-centered nutrition education for participants in the Special Supplemental Nutrition Program for Women, Infants, and Children
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Learner-centered nutrition education for food stamp recipients
Number of subjects: 155
Study: 15961531

Group type: EXPERIMENTAL
Intervention: C12 (0.4 kcal/min)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: C12 (0.1 kcal/min)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: C12 (0.2 kcal/min)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Control (saline; rate 4 ml/min)
Number of subjects: 13
Study: 12165184

Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 106

Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 106
Study: 9695210

Group type: EXPERIMENTAL
Intervention: piperacillin/tazobactam 4.5 g every 8 h i.v.
Number of subjects: 83

Group type: COMPARATOR
Intervention: ceftazidime 2 g every 8 h plus amikacin 15 mg/kg i.v. per day
Number of subjects: 83
Study: 7664601

Group type: EXPERIMENTAL
Intervention: 100mg sodium prasterone sulfate
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: 200mg sodium prasterone sulfate
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 120